Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.
Jun-Xu Li, Kenner C Rice, Charles P France
Journal of Pharmacology and Experimental Therapeutics February 1, 2008 DOI: 10.1124/jpet.107.130625 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Drug discrimination study Peer reviewed |
|---|---|
| Sample size | 4 |
| Population | Rhesus monkeys |
| Interventions | DOM ritanserin ketanserin MDL100907 MDL100009 haloperidol quipazine (-)DOM 2C-T-7 U-50488 salvinorin A ketamine phencyclidine amphetamine methamphetamine cocaine morphine yohimbine fenfluramine 8-OH-DPAT N-0434 |
| Dose | 0.32 mg/kg |
| Keywords | Hallucinogens Psychoactive drugs Psychedelics Psychotomimetics Serotonin receptors 5-ht2a receptors 5-HT Receptors Neuroreceptors Drug mechanisms Mechanism of action Neuropharmacology Psychopharmacology Receptor pharmacology Drug discrimination Animal models Behavioral pharmacology Drug testing |
| Citations | 51 |
| Key points | The discriminative stimulus effects of DOM in monkeys are mediated primarily by 5-HT2A receptors, and not all hallucinogens share these effects, as salvinorin A did not substitute for DOM. |
Abstract
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) and related drugs have been studied extensively in rodents, although the generality of those findings across species is not known. The goals of this study were to see whether monkeys could discriminate DOM and to characterize the DOM discriminative stimulus by studying a variety of drugs, including those with hallucinogenic activity in humans. Four rhesus monkeys discriminated between 0.32 mg/kg s.c. DOM and vehicle after an average of 116 (range = 85-166) sessions while responding under a fixed ratio 5 schedule of stimulus shock termination. Increasing doses of DOM occasioned increased responding on the drug lever with the training dose occasioning DOM-lever responding for up to 2 h. The serotonin (5-HT)(2A/2C) receptor antagonists ritanserin and ketanserin, the 5-HT(2A) receptor antagonist (+)2,3-dimethoxyphenyl-1-[2-(4-piperidine)-methanol] (MDL100907), and its (-)stereoisomer MDL100009 [(-)2,3-dimethoxyphenyl-1-[2-(4-piperidine)-methanol], but not haloperidol, completely blocked the discriminative stimulus effects of DOM. Quipazine as well as several drugs with hallucinogenic activity in humans, including (+)lysergic acid diethylamide, (-)DOM, and 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), occasioned DOM-lever responding. The kappa-opioid receptor agonists U-50488 and salvinorin A (a hallucinogen) did not exert DOM-like effects and neither did ketamine, phencyclidine, amphetamine, methamphetamine, cocaine, morphine, yohimbine, fenfluramine, 8-hydroxy-2-(dipropylamino)tetralin hydrobromide (8-OH-DPAT), or (+/-)-2-(N-phenethyl-N-1'-propyl)amino-5-hydroxytetralin hydrochloride (N-0434). These data confirm in nonhuman primates a prominent role for 5-HT(2A) receptors in the discriminative stimulus effects of some drugs with hallucinogenic activity in humans. The failure of another drug with hallucinogenic activity (salvinorin A) to substitute for DOM indicates that different classes of hallucinogens exert qualitatively different discriminative stimulus effects in nonhumans.
Citations in the library
Cited by 32
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Animal Models of Serotonergic Psychedelics ACS Chemical Neuroscience September 24, 2012
- Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacological Reviews June 1, 2011
- Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders Frontiers in Pharmacology September 8, 2015
- Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology March 1, 2012
and 27 more in the library
Cites 21
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence November 8, 2006
- The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology March 1, 2004
- Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD) Psychopharmacology 1987
- Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology September 1, 2005
and 16 more in the library